Jemma Arakelyan, Chief Executive Officer at The Institute of Cancer and Crisis, shared a post by The Institute of Cancer and Crisis (ICC), on LinkedIn, adding:
“Christos Tsagkaris, we’re glad to have you on board and want to express our sincere thanks for the great work you do.
Your contributions through the EU cancer mission and as an The Institute of Cancer and Crisis (ICC) Board Member make a significant difference!”
Quoting The Institute of Cancer and Crisis (ICC)’s post on LinkedIn:
“The Institute of Cancer and Crisis (ICC) participated in the ‘Emergency Medicine and Intensive Care: Modern Issues’ International Conference, held on 14–15 November 2025 in Tbilisi, Georgia.
As part of the conference, the Institute of Cancer and Crisis (ICC) was represented in a growing dialogue on the intersection of oncology, crisis preparedness, and resilient health systems.
Dr. Christos Tsagkaris delivered an invited lecture on the EU Cancer Mission, focusing on the vital intersection of cancer, crisis, and preparedness in his capacity as a member of the EU Cancer Mission Board.
A related piece highlighting the mission, rationale, and ongoing activities of the ICC, penned by Dr. Jemma Arakelyan, MD, PhD, CEO of the ICC, and Dr. Christos Tsagkaris, Member of the ICC’s Board of Directors, was published in the collective conference proceedings in Georgian Scientists. The piece outlines the emerging challenges cancer patients face during conflicts, disasters, and large-scale emergencies, and presents the ICC’s approach to research, advocacy, and system-level preparedness.
Dr. Christos Tsagkaris attended the event in person and delivered an invited lecture on the EU Cancer Mission, focusing on cancer, crisis, and preparedness in his capacity as a member of the EU Cancer Mission Board.”
Read the full article.
Read more posts featuring Jemma Arakelyan on OncoDaily.